Filing Flows › Outset Medical (OM) › Q2 2026 › vs Q2 2025
Outset Medical (OM) Q2 2026 vs Q2 2025 (year over year)
Outset Medical's revenue rose $216K (+0.7%) from $31.4M in Q2 2025 to $31.6M in Q2 2026. The biggest changes: Service and Other Revenue +$1.4M (+17%); Product −$1.2M (-5%).
Outset Medical, Q2 2026: revenue $31.6M (+0.7% year over year), operating margin -49.6%, net loss $18.0M, operating cash flow −$9.6M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Consumables Product | $12.4M | $14.2M | −$1.7M | -12% |
| Consoles Product | $9.5M | $8.9M | $558K | +6% |
| Product | $21.9M | $23.1M | −$1.2M | -5% |
| Service and Other Revenue | $9.7M | $8.3M | $1.4M | +17% |
| Revenue | $31.6M | $31.4M | $216K | +0.7% |
| Net loss | $18.0M | $18.5M | −$557K | -3% |
| Costs & expenses | $49.6M | $50.0M | −$341K | -0.7% |
| Operating costs | $47.3M | $48.3M | −$973K | -2% |
| Interest & other, net | $2.1M | $1.6M | $516K | +33% |
| Income tax | $220K | $104K | $116K | +112% |
| Cost of revenue | $18.4M | $19.6M | −$1.2M | -6% |
| Research & development | $5.5M | $5.3M | $161K | +3% |
| Sales & marketing | $12.2M | $14.3M | −$2.1M | -15% |
| General & admin | $11.4M | $9.2M | $2.2M | +24% |
| Operating cash sources | $18.0M | $18.5M | −$557K | -3% |
| Depreciation & amortization | $627K | $1.2M | −$528K | -46% |
| Share-based compensation | $2.7M | $3.5M | −$800K | -23% |
| Working capital & other | $5.0M | $9.1M | −$4.0M | -45% |
| Cash used in operations | $9.6M | $4.8M | $4.8M | +100% |
| Net loss absorbed | $18.0M | $18.5M | −$557K | -3% |
Questions
How much did Outset Medical's revenue grow year over year in Q2 2026?
Outset Medical's revenue rose $216K (+0.7%) from $31.4M in Q2 2025 to $31.6M in Q2 2026.
What drove Outset Medical's revenue change in Q2 2026?
Service and Other Revenue +$1.4M (+17%); Product −$1.2M (-5%).